To improve understanding of diabetic macular edema (DME) and encourage earlier engagement with eye care, particularly among underserved communities, by addressing stigma and promoting education.
Key Findings:
DME affects an estimated 750,000 people in the US and is a leading cause of vision loss among individuals with diabetes, highlighting the urgent need for awareness.
Around 60% of Americans with diabetes miss their recommended annual eye examinations, indicating a significant gap in care.
People of color are two to three times more likely to develop vision-threatening complications, underscoring the need for targeted interventions.
Interpretation:
The campaign aims to address gaps in awareness and screening uptake through culturally relevant messaging and lived experiences, ensuring that the information resonates with diverse populations.
Limitations:
Awareness and screening uptake remain suboptimal despite the initiative, with many individuals still unaware of their risk.
The burden of DME is disproportionately higher in certain populations, necessitating focused outreach efforts.
Conclusion:
The initiative is part of Genentech's commitment to addressing disparities in vision care and promoting earlier intervention in chronic retinal diseases, especially as diabetes prevalence continues to rise.
